Overview

Observational Study to Evaluate the Safety While Using LevemirĀ®

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Africa. The aim of this observational study is to evaluate the incidence of serious adverse drug reactions while using insulin LevemirĀ® under normal clinical practice conditions in Egypt.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir